Year archive

NEXSEN LIMITED — 2026 filings

All 18 regulatory filings released by NEXSEN LIMITED (NXN) in 2026, sourced directly from the official regulator.

18 Filings

2026 Period

2026 filings (18)

Filing	Released	Lang
Becoming a substantial holder 3 pages 1.5MB Major Shareholding Notification	2026-05-14	English
Nexsen secures first hospital partner in Asia 5 pages 3.5MB Regulatory Filings	2026-05-12	English
Nexsen and Universiti Malaya launch joint facility 4 pages 766.5KB Regulatory Filings	2026-05-03	English
Quarterly Report - Q3 FY26 12 pages 1.8MB Interim / Quarterly Report Q3 2026	2026-04-27	English
QMS milestone achieved 3 pages 745.2KB Regulatory Filings	2026-04-06	English
HK$6 million grant awarded to advance Asia-Pacific execution 4 pages 3.9MB Regulatory Filings	2026-03-30	English
Nexsen accelerates global rollout for StrepSure 5 pages 219.8KB Regulatory Filings	2026-03-25	English
FDA feedback derisks US approval pathway for StrepSure 3 pages 737.1KB Regulatory Filings	2026-03-22	English
Change in substantial holding - Nexsen 7 pages 2.4MB Regulatory Filings	2026-02-26	English
Half Yearly Report and Accounts 21 pages 1.5MB Regulatory Filings	2026-02-26	English
Application for quotation of securities - NXN 5 pages 16.6KB Regulatory Filings	2026-02-24	English
Nexsen highlights GBS strategy at ISSAD 2026 12 pages 10.4MB Regulatory Filings	2026-02-24	English
Application for quotation of securities - NXN 5 pages 16.7KB Regulatory Filings	2026-02-05	English
Change in substantial holding - Nexsen 8 pages 2.4MB Regulatory Filings	2026-02-05	English
Quarterly Report - Q2 FY26 10 pages 1.9MB Regulatory Filings	2026-01-28	English
$500k govt grant expands GBS project to neonates 3 pages 877.8KB Regulatory Filings	2026-01-26	English
Notice under ASX Listing Rule 3.10A 1 page 760.8KB Regulatory Filings	2026-01-22	English
Business Update - FDA engagement underway & key appointment 4 pages 880.6KB Regulatory Filings	2026-01-05	English